EUVIMEDEUVIMED entdecken
Crossref

OVOL1 targets YAP to suppress esophageal squamous cell carcinoma progression

Zhaofang Yan, Yaqi Li, Jinping Li, Shuxian Huang, Hao Lan, Genjian Hu, Chichu Xie, Guangying Qi, Jinfeng Gan

Cellular Signalling · 2026

DOI: 10.1016/j.cellsig.2026.112628 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cellular Signalling, 2026. Verfasst von Zhaofang Yan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Guangxi Key Laboratory of Tumor Immunology and Microenvironmental Regulation, Guilin Medical University, Guilin, China; Guangxi Health Commission Key…. Hauptthemen laut MEDLINE: Esophageal Neoplasms, Esophageal Squamous Cell Carcinoma, Transcription Factors, Adaptor Proteins, Signal Transducing. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Guangxi Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Abnormal regulation of OVO-like proteins (OVOLs) has been recognized as an important contributor to cancer development. Ovo like transcriptional repressor 1 (OVOL1), a member of the OVOL family, has been reported to function either as a tumor suppressor or as an oncogene in different cancer types; however, its role in esophageal squamous cell carcinoma (ESCC) has not been clearly defined. METHODS: The expression of OVOL1 in ESCC was examined using multiple independent patient cohorts, and its clinical significance was further evaluated. The functional role of OVOL1 in ESCC cells was determined through both in vitro and in vivo experiments. To elucidate the underlying mechanisms, RNA-seq, luciferase reporter, co-immunoprecipitation, and chromatin immunoprecipitation (ChIP) assays were performed. RESULTS: Reduced OVOL1 expression was frequently observed across multiple ESCC cohorts and was associated with poor clinical outcomes. Both in vitro and in vivo experiments showed that enforced OVOL1 expression suppresses ESCC cell proliferation, stemness-associated traits, and lung metastasis caused by tail vein injection of ESCC cells in mice, whereas OVOL1 knockdown enhances these malignant behaviors. Mechanistically, OVOL1 represses Yes1-associated transcriptional regulator (YAP) transcription, which is likely achieved through a histone deacetylase (HDAC)-dependent mechanism, thereby limiting ESCC progression. CONCLUSION: OVOL1 acts as a tumor suppressor in ESCC, in part by suppressing YAP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Esophageal NeoplasmsEsophageal Squamous Cell CarcinomaTranscription FactorsAdaptor Proteins, Signal TransducingDNA-Binding ProteinsPhosphoproteinsHumansAnimalsCell Line, TumorDisease ProgressionYAP-Signaling ProteinsCell ProliferationGene Expression Regulation, NeoplasticMiceCell Cycle ProteinsMice, Nude

Stichwörter der Autor:innen

Esophageal squamous cell carcinomaOVOL1YAP

Substanzen

Transcription FactorsAdaptor Proteins, Signal TransducingYAP-Signaling ProteinsYAP1 protein, humanDNA-Binding ProteinsCell Cycle ProteinsPhosphoproteins

Autor:innen und Institutionen

  • Guangxi Key Laboratory of Tumor Immunology and Microenvironmental Regulation, Guilin Medical University, Guilin, China; Guangxi Health Commission Key Laboratory of Tumor Immunology and Receptor-Targeted Drug Basic Resea…
  • Department of Histology and Embryology, School of Preclinical Medicine, Guilin Medical University, Guilin, China.

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Guangxi Province

Zitieren

APA

Yan, Z., Li, Y., Li, J., Huang, S., Lan, H., Hu, G., Xie, C., Qi, G., & Gan, J. (2026). OVOL1 targets YAP to suppress esophageal squamous cell carcinoma progression. Cellular Signalling. https://doi.org/10.1016/j.cellsig.2026.112628

Vancouver

Yan Z, Li Y, Li J, Huang S, Lan H, Hu G, et al. OVOL1 targets YAP to suppress esophageal squamous cell carcinoma progression. Cellular Signalling. 2026. doi:10.1016/j.cellsig.2026.112628

BibTeX
@article{Yan2026,
  author = {Yan, Zhaofang and Li, Yaqi and Li, Jinping and Huang, Shuxian and Lan, Hao and Hu, Genjian and Xie, Chichu and Qi, Guangying and Gan, Jinfeng},
  title = {OVOL1 targets YAP to suppress esophageal squamous cell carcinoma progression},
  journal = {Cellular Signalling},
  year = {2026},
  doi = {10.1016/j.cellsig.2026.112628}
}
Kostenlos starten →